Metrochem API

What Metrochem API does

Metrochem API is an India-based, privately held pharmaceutical manufacturer headquartered in Hyderabad, founded in 2004. The company produces Active Pharmaceutical Ingredients (APIs), pellets (semi-finished formulations), and chemical intermediates, positioning itself as a B2B supplier to the generic pharmaceutical industry.

The firm operates under the metroapi.com web presence and employs between 501 and 1,000 staff, a scale consistent with a mid-sized Indian API and intermediate manufacturer running multiple production lines for regulated pharmaceutical inputs. As a B2B manufacturer, Metrochem API serves downstream formulators and generic drug developers that require API and intermediate inputs compliant with pharmaceutical quality standards. Its product scope spans APIs alongside semi-finished pellet formulations, giving it a presence at two points of the pharmaceutical value chain.

The revenue model is consistent with a standard pharmaceutical intermediate supply business: catalog and/or contract manufacturing with regulatory-grade output sold to generic drug formulators. Available data is sparse - the company does not disclose revenue, pricing, leadership, customers, partnerships, funding, or regulatory certifications in the input material, and no parent-subsidiary or investor ownership structure is referenced. Any deeper analysis of unit economics, customer mix, geographic exposure, or growth cadence would require additional disclosure beyond what is available in the source data.

Name

Metrochem API

Website

https://metroapi.com

Company type

Private

Founded year

2004

Headcount range

501–1,000 employees

Short description

Metrochem API is a Hyderabad-headquartered Indian pharmaceutical manufacturer, founded in 2004, producing active pharmaceutical ingredients, pellets, and chemical intermediates for B2B generic drug formulators.

Ownership category

akta.pro rank

Product category

Active Pharmaceutical Ingredients (API) Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Small-Molecule API Commercial Manufacturing (HLAGAHAB)

akta.pro secondary industries

Small-Molecule API & Intermediates CDMO (HLAGABAA), Generic APIs & Intermediates (Active Ingredients) (HLAIABAG)

Keywords

• Active Pharmaceutical Ingredients
• Pharmaceutical Intermediates
• Pellet Formulations
• API Manufacturing
• Pharmaceutical Manufacturing

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Core offering

Metrochem API manufactures and supplies Active Pharmaceutical Ingredients (APIs), Pellets (Semi-finished Formulations), and pharmaceutical Intermediates. The company produces these pharmaceutical inputs for use by downstream drug formulators and generic drug manufacturers in the pharmaceutical supply chain.

Differentiator

Problem solved

Functional benefit

Products and services

• Active Pharmaceutical Ingredients (APIs) Manufactured active pharmaceutical ingredients supplied to pharmaceutical formulators and generic drug manufacturers for use in finished drug formulations.
• Pellets (Semi-finished Formulations) Manufactured pelletized semi-finished pharmaceutical formulations supplied as intermediate dosage forms to pharmaceutical companies for further processing into finished drug products.
• Pharmaceutical Intermediates Manufactured chemical intermediates used as raw inputs in the synthesis of active pharmaceutical ingredients, supplied to API producers and pharmaceutical manufacturers.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• Divis Laboratories: Leading Indian manufacturer of APIs and intermediates with significant custom synthesis operations. Direct peer in small-molecule API commercial manufacturing, with comparable Hyderabad-headquartered operations and customer base overlap.
• Laurus Labs: Indian API and formulation manufacturer with strong presence in APIs, intermediates, and finished dosages. Comparable product portfolio spanning APIs and semi-finished formulations, and overlapping customer base in generics.
• Aurobindo Pharma: One of India's largest vertically integrated API and generic finished dosage manufacturers. Directly comparable in API manufacturing, pellet production, and intermediates, with overlapping global generics customers.
• Neuland Laboratories: Indian API and contract development/manufacturing organization (CDMO) with focus on small-molecule APIs and intermediates. Highly comparable business model, scale, and Hyderabad-based operations.
• Granules India: Indian manufacturer of APIs, pharmaceutical formulation intermediates (PFIs), and finished dosages with strong pellet capabilities. Direct overlap with Metrochem's APIs-and-pellets positioning.
• SMS Pharmaceuticals: Indian API and intermediate manufacturer serving global generic and innovator customers. Comparable scale, product mix, and India-based export-oriented operations.
• Hetero Drugs: Large Indian manufacturer of APIs, intermediates, and formulations with strong ARV and specialty API portfolio. Comparable in API/intermediates manufacturing and global regulated market exposure.
• Sri Krishna Pharmaceuticals (Srikem Labs): Indian API and intermediate manufacturer producing APIs and advanced intermediates. Direct comparable in scope of small-molecule API commercial manufacturing.

Broad incumbents

• Piramal Pharma Solutions: India-based global CDMO and API manufacturer with broader services across the drug development lifecycle. Comparable in API/intermediates manufacturing but operates at significantly larger scale and offers adjacent services.
• Zydus Lifesciences (Cadila): Major Indian pharmaceutical company with vertically integrated API and formulation operations. Overlaps in API manufacturing but is substantially larger and broader in finished dosage and biologics.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/MetrochemAPI

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Metrochem API